Mariposa Health Overview
- Founded
-
2008
- Status
-
Acquired/Merged
- Latest Deal Type
-
M&A
- Financing Rounds
-
3
Mariposa Health General Information
Description
Developer of pharmaceutical technology and products intended for the treatment of conditions causing chronically poor airflow to the lungs. The company's health and pharmaceutical research and development provide a pronged complementary approach through anti-inflammatory/anti-oxidant and an oral bacterial vaccine for the treatment of Chronic Obstructive Pulmonary Disease (COPD) from its early to severe stages, enabling patients to get treatment for lung and inflammatory conditions.
Contact Information
Website
www.mariposahealth.com.au
Ownership Status
Acquired/Merged
(Operating Subsidiary)
(Operating Subsidiary)
Financing Status
Corporate Backed or Acquired
Primary Industry
Biotechnology
Other Industries
Drug Discovery
Pharmaceuticals
Parent Company
Mariposa Health US
Primary Office
- 61 Avalon Parade
- Unit 6
- Avalon Beach, New South Wales 2107
- Australia
Mariposa Health Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Mariposa Health Patents
Mariposa Health Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-20060235045-A1 | Therapeutic agent for chronic obstructive pulmonary disease and method for treatment for chronic obstructive pulmonary disease with the same | Active | 30-Jul-2003 | 00000000000 | 0 |
| AU-2004261527-A1 | Therapeutic agent for chronic obstructive pulmonary disease and method of treatment for chronic obstructive pulmonary disease with the same | Active | 30-Jul-2003 | 00000000000 | |
| CA-2533919-A1 | Therapeutic agent for chronic obstructive pulmonary disease and method for treating chronic obstructive pulmonary disease using the same | Active | 30-Jul-2003 | 00000000000 | |
| CA-2533919-C | Therapeutic agent for chronic obstructive pulmonary disease and method for treating chronic obstructive pulmonary disease using the same | Inactive | 30-Jul-2003 | 00000000000 | |
| EP-1650191-A1 | Therapeutic agent for chronic obstructive pulmonary disease and method of treatment for chronic obstructive pulmonary disease with the same | Active | 30-Jul-2003 | A61K31/4704 |
Mariposa Health Executive Team (1)
| Name | Title | Board Seat | Contact Info |
|---|---|---|---|
| Phillip Comans | Managing Director, Executive Chairman, Founder & President |
Mariposa Health Board Members (1)
| Name | Representing | Role | Since |
|---|---|---|---|
| 0000000 000000 | Mariposa Health | Managing Director, Executive Chairman, Founder & President | 000 0000 |